Skip to content
Awesome Websites
Sign in

Channel

Metabolic Peptides

Articles examining metabolic and GLP-1 peptide research, its limitations and regulatory context.

Visit Metabolic Peptides

4 articles

5 Evidence-Based Strategies to Manage GLP-1 Gastrointestinal Side Effects in Research

5 Evidence-Based Strategies to Manage GLP-1 Gastrointestinal Side Effects in Research

Gastrointestinal adverse events are the leading cause of dose reduction and discontinuation in GLP-1 receptor agonist re…

Oct 15, 2026

Semaglutide vs Liraglutide: What Separates Two Generations of GLP-1 Science

Semaglutide vs Liraglutide: What Separates Two Generations of GLP-1 Science

Both molecules activate the same GLP-1 receptor, yet semaglutide produces roughly double the weight loss of liraglutide.…

Sep 30, 2026

Retatrutide: What the Phase 2 Data Actually Show About the Triple Agonist

Retatrutide: What the Phase 2 Data Actually Show About the Triple Agonist

A 24% mean weight reduction with no sign of plateau at 48 weeks sounds extraordinary. But phase 2 data require careful i…

Sep 15, 2026

Dual Incretin Agonism Explained: Why Activating Two Receptors Beats One

Dual Incretin Agonism Explained: Why Activating Two Receptors Beats One

For decades, GLP-1 receptor agonism was the gold standard in metabolic peptide research. Then dual incretin science arri…

Aug 22, 2026

Get the weekly digest

The best new articles across all channels, once a week. No spam, one-click unsubscribe.